Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ZFGN > SEC Filings for ZFGN > Form 8-K on 18-Feb-2016All Recent SEC Filings

Show all filings for ZAFGEN, INC.

Form 8-K for ZAFGEN, INC.


18-Feb-2016

Other Events


Item 8.01 Other Events

On February 18, 2016, Zafgen, Inc. issued a press release announcing the top-line results from its Phase 2b trial of beloranib in severe obesity complicated by type 2 diabetes. A copy of the press release is filed herewith as Exhibit 99.1 to this Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Exhibits.

(d) Exhibits

Exhibit
No. Description

99.1 Press release issued by Zafgen, Inc. on February 18, 2016.


  Add ZFGN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ZFGN - All Recent SEC Filings
Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.